Knowledge Translation for Patients With Acute Coronary Syndromes
NCT ID: NCT02672137
Last Updated: 2016-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
4604 participants
INTERVENTIONAL
2010-01-31
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhancing Recovery in Coronary Heart Disease (ENRICHD) Patients
NCT00000557
Geriatric-CO-mAnagement for Cardiology Patients in the Hospital
NCT02890927
Study of the Effectiveness of Report Cards on the Quality of Care for Heart Attack and Heart Failure Patients
NCT00187460
Prevention of Early Readmission in Elderly Congestive Heart Failure Patients
NCT00000475
Study of the Efficiency of Education About Cardiovascular Risk Factors in Patients After an Acute Coronary Syndrome
NCT00337480
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
EBMT was pre-defined as in-hospital anticoagulation and discharge prescription of dual anti-platelets, beta-blockers, statins, and angiotensin pathway modulating agents (for patients with impaired left ventricular systolic function). Refusal, impaired cognitive function, allergy or intolerance of patients to any of EBMT were considered valid reasons for withholding EBMT.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
knowledge translation
knowledge translation 12-month multi-facet intensive knowledge translation measures that include: Community of practice, local gap analysis, opinion leaders, targeted interventions, performance feedback, reminders and local formation of ACS teams.
knowledge translation
knowledge translation that include: Community of practice, local gap analysis, opinion leaders, targeted interventions, performance feedback, reminders and local formation of ACS teams.
Usual care
no intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
knowledge translation
knowledge translation that include: Community of practice, local gap analysis, opinion leaders, targeted interventions, performance feedback, reminders and local formation of ACS teams.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Myocardial infarction without ST-segment elevation
3. Unstable angina
4. Acute coronary syndromes -
Exclusion Criteria
2. Hospital stay of less than 48 hours -
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sanofi
INDUSTRY
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Fonds de la Recherche en Santé du Québec
OTHER_GOV
Montreal General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thao Huynh
Cardiologist, associate professor of medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
thao huynh, md,msc,phd
Role: PRINCIPAL_INVESTIGATOR
Montreal General Hospital
References
Explore related publications, articles, or registry entries linked to this study.
Huynh T, Kouz S, Afilalo M, Rinfret S, Schampaert E, Mansour S, Montigny M, Eisenberg MJ, Lauzon C, Dery JP, Nguyen M, L'Allier P, Harvey R, Boudreault C, Tardif JC. Knowledge Translation to improve prescription of evidence-based medical therapy for patients admitted with acute coronary syndromes: insights from the AMI-OPTIMA study. Journal of the American College of Cardiology.J Am Coll Cardiol. 2015;65(10_S).
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DIREG_L_04201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.